Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog.

Autor:	Magkouta S; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Marianthi Simou and G.P. Livanos Labs, 1st Department of Critical Care and Pulmonary Services, School of Medicine, National & Kapodistrian University of Athens,'Evangelismos' Hospital, Athens, Greece.; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK., Veroutis D; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK., Papaspyropoulos A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Georgiou M; Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece., Lougiakis N; Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece., Pippa N; Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, Athens, Greece., Havaki S; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Palaiologou A; Center of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Thanos DF; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Kambas K; Hellenic Pasteur Institute, Athens, Greece., Lagopati N; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Laboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Biomedical Research Foundation, Academy of Athens, Athens, Greece., Boukos N; Institute of Nanoscience and Nanotechnology, National Center for Scientific Research 'Demokritos', Agia Paraskevi, Greece., Pouli N; Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece., Marakos P; Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece., Kotsinas A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Thanos D; Biomedical Research Foundation, Academy of Athens, Athens, Greece., Evangelou K; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Sampaziotis F; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Tamvakopoulos C; Center of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Pispas S; Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, Athens, Greece., Petty R; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK., Kotopoulos N; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Gorgoulis VG; Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. vgorg@med.uoa.gr.; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. vgorg@med.uoa.gr.; Biomedical Research Foundation, Academy of Athens, Athens, Greece. vgorg@med.uoa.gr.; Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK. vgorg@med.uoa.gr.; Intelligencia, Inc., New York, NY, USA. vgorg@med.uoa.gr.
Jazyk:	angličtina
Zdroj:	Nature aging [Nat Aging] 2024 Dec 27. Date of Electronic Publication: 2024 Dec 27.
DOI:	10.1038/s43587-024-00747-4
Abstrakt:	The emerging field of senolytics is centered on eliminating senescent cells to block their contribution to the progression of age-related diseases, including cancer, and to facilitate healthy aging. Enhancing the selectivity of senolytic treatments toward senescent cells stands to reduce the adverse effects associated with existing senolytic interventions. Taking advantage of lipofuscin accumulation in senescent cells, we describe here the development of a highly efficient senolytic platform consisting of a lipofuscin-binding domain scaffold, which can be conjugated with a senolytic drug via an ester bond. As a proof of concept, we present the generation of GL392, a senolytic compound that carries a dasatinib senolytic moiety. Encapsulation of the GL392 compound in a micelle nanocarrier (termed mGL392) allows for both in vitro and in vivo (in mice) selective elimination of senescent cells via targeted release of the senolytic agent with minimal systemic toxicity. Our findings suggest that this platform could be used to enhance targeting of senotherapeutics toward senescent cells. Competing Interests: Competing interests: Described compounds are in patent pending status: (1) Greek Patent Application No. 20240100309, (2) UK Patent Application No. GB2406749.8 and (3) international Patent Cooperation Treaty filing. Patent competing interests concern N.K. and V.G.G. only. The other authors declare no competing interests. (© 2024. The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink